Head-to-head Study of Tegoprazan 50 mg BID Plus Amoxicillin 1 g TID vs. Vonoprazan 20 mg BID Plus Amoxicillin 1 g TID for H. Pylori Eradication

Clinical trial NCT07242456 · RECRUITING

Trial details

NCT number: NCT07242456
Sponsor: First People's Hospital of Hangzhou
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Helicobacter Pylori Infection

Start date: 2025-02-17
Primary completion: 2025-11-15
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.